Tag: drug injury
-
Summer 2016 Update On Diabetes Medicines Invokana / Farxiga / Jardiance: Drug Label Changes And Safety Investigations
According To Drug Regulators, New Possible Side Effects Include: Fatal Cases Of Ketoacidosis; Leg, Foot, And Toe Amputations; And, Lactic Acidosis (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: Invokana “Black-Box Warning” For…
-
Summer 2016 Update On ED Drugs Viagra / Cialis / Levitra: Medical And Legal Developments
Melanoma Skin Cancer: FDA Is Evaluating The Need For Regulatory Action; More Lawsuits Filed; Another Research Study (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________ UPDATE: IN RE: Viagra (Sildenafil Citrate) and Cialis (Tadalafil)…
-
Zecuity Recall: Teva Migraine Drug Patch Gets FDA Warning About Reports Of Serious Burns And Potential Permanent Scarring
Drug Company Announces It Will Recall Zecuity Skin Patches From Pharmacies As Well As Temporarily Suspend Sales, Marketing, And Distribution Of Product (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: Zecuity Migraine…
-
Lyrica Associated With Higher Risk Of Major Birth Defects When Taken During First Trimester Of Pregnancy According To Recent European Medical Study
Animal Studies Have Lyrica Possibly Linked To Skeletal Malformations, Neural Tube Defects, And Other Abnormalities, But Safety Data On Lyrica Use During Human Pregnancy Are Scarce (Posted by Tom Lamb at DrugInjuryWatch.com) …
-
A Tecfidera Label Change Modifying Warnings About Progressive Multifocal Leukoencephalopathy (PML) Was Done In February 2016 With Little Notice
Biogen Idec First Added Information About Tecfidera Being Assoicated With PML Brain Infection Back In December 2014, After An FDA Drug Safety Communication Was Issued (Posted by Tom Lamb at DrugInjuryWatch.com) Tecfidera…
-
Acute Kidney Injury Caused By Heartburn Medicines In Class Of Drugs Called Proton Pump Inhibitors (PPIs), Such As Nexium, Prilosec, And Prevacid
PPI-Induced Acute Interstitial Nephritis Is A Kidney-Related Side Effect That Has Been Known About For Many Years, But FDA Only Mandated A Drug Label Change In December 2014 (Posted by Tom Lamb at…
-
Possible Linzess Recall By FDA Suggested By Phase Five Research Analyst Report, Which Has Become A Bit Of A Mystery
Here Are Some Of The "Findings" From An April 26, 2016 Document Which Seems To Have Disappeared Only Two Days Later (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: "Synergy Petitions FDA…